ArticleCureus2025
Correlation of Pre-colonoscopy Blood Hemoglobin Levels With Significant Colorectal Pathology Among Fecal Immunochemical Test-Positive Patients.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Fecal immunochemical testing (FIT) is a widely implemented noninvasive screening tool for colorectal cancer (CRC). While FIT detects occult gastrointestinal (GI) bleeding, the relationship between systemic blood hemoglobin (Hb) levels and significant colorectal pathology (SCP) among FIT-positive patients remains uncertain. Identifying such an association could improve clinical triage and resource allocation in screening programs. Methodology This retrospective observational study was conducted at Prince Sultan Military Medical City, Riyadh, Saudi Arabia. All adults (≥18 years) who tested positive on FIT and subsequently underwent complete colonoscopy between December 2024 and September 2025 were included. Patients with incomplete colonoscopy, inadequate bowel preparation, missing Hb data, active non-colorectal GI bleeding, hematologic disorders, or prior colorectal surgery or malignancy were excluded. Pre-colonoscopy Hb was obtained within 12 weeks of colonoscopy. SCP was defined as tubular adenoma, tubulovillous adenoma, or adenocarcinoma. Hb levels were compared across pathology groups using the Kruskal-Wallis test, and anemia prevalence was analyzed using the chi-square test. Results Among 483 FIT-positive patients, 182 met the inclusion criteria. The mean age was 59.3 ± 11.8 years, and 55% were male. The median pre-colonoscopy Hb level was 13.9 g/dL (interquartile range (IQR) 12.7-15.0). Histopathology revealed tubular adenoma in 89 (48.9%), tubulovillous adenoma in 35 (19.2%), adenocarcinoma in 23 (12.6%), hyperplastic polyps in 16 (8.8%), and other benign lesions in 19 (10.4%). Median Hb differed slightly across groups, lowest in adenocarcinoma (12.8 g/dL) and highest in benign lesions (14.8 g/dL), but the difference was not statistically significant (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.